台股 » 個股 » 台康生技 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

台康生技

(6589)
可現股當沖
  • 股價
    71.4
  • 漲跌
    ▲0.3
  • 漲幅
    +0.42%
  • 成交量
    849
  • 產業
    上櫃 生技醫療類股
  • 524人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
台康生技 (6589)籌碼相關-永豐金-信義 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

永豐金-信義 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/12/20372.6700.0071.7031,2330.24%
2024/12/1700.00272.0074.60-21,244-0.16%
2024/12/16268.1000.0069.5021,2230.16%
2024/12/13568.1200.0068.0051,1860.42%
2024/12/12373.2300.0073.5031,1100.27%
2024/12/11176.60278.4076.60-11,045-0.10%
2024/12/1000.005682.9082.90-56945-5.92%
2024/12/0900.00193.1092.10-1932-0.11%
2024/12/06190.90391.2790.20-2914-0.22%
2024/12/025695.05295.8093.30548766.16%
2024/11/2900.00293.2594.20-2845-0.24%
2024/11/2800.00292.7592.10-2812-0.25%
2024/11/2700.00393.3391.10-3797-0.38%
2024/11/12189.20189.4089.4007360.00%
2024/11/11191.0000.0090.7017230.14%
2024/11/0800.00991.9691.70-9719-1.25%
2024/11/0500.00493.9594.10-4691-0.58%
2024/11/0400.00494.0092.60-4690-0.58%
2024/10/2800.00389.3089.50-3593-0.51%
2024/09/26188.5000.0086.2018610.12%
2024/09/24192.203093.0191.50-29937-3.09%
2024/09/233093.1900.0094.00309373.20%
2024/09/0300.001585.1084.60-151,203-1.25%
2024/09/021585.2000.0085.10151,2121.24%
2024/08/0700.00181.0081.10-11,219-0.08%
2024/08/05178.00177.3077.3001,2000.00%
2024/07/2900.00187.4085.90-11,154-0.09%
2024/07/1700.001094.6294.30-101,101-0.91%
2024/07/16194.4000.0092.7011,0880.09%
2024/07/151093.78193.3093.7091,0850.83%
2024/07/1200.00191.9091.20-11,068-0.09%
2024/07/03395.231.195.6394.901.91,0220.19%
2024/07/0100.002194.2696.50-21891-2.35%
2024/06/282090.770.190.1090.50208042.48%
2024/06/27389.6000.0088.0037810.38%
2024/06/2600.000.190.8090.60-0.1756-0.01%
2024/06/2100.000.186.2086.60-0.1686-0.01%
2024/06/20286.051085.7886.10-8673-1.19%
2024/06/19384.3700.0083.8036550.46%
2024/06/18285.002.186.4785.10-0.1650-0.01%
2024/06/14484.35286.4084.0026430.31%
2024/06/1300.00184.1083.90-1637-0.16%
2024/06/12987.11386.9084.5066220.96%
2024/06/11286.30186.3086.3015420.18%
2024/06/0400.000.179.6079.30-0.1506-0.01%
2024/05/2400.000.879.6079.60-0.8547-0.14%
2024/05/14181.5000.0082.3015630.18%
2024/04/2900.00079.7081.1006710.00%
2024/04/2600.000.178.7078.70-0.1668-0.01%
2024/04/19278.0000.0077.0026740.30%
2024/04/1600.000.179.3079.10-0.1667-0.01%
2024/04/15183.7000.0082.3016520.15%
2024/04/08185.9000.0085.9016530.15%
2024/03/28187.9000.0088.0016630.15%
2024/03/2000.00186.0085.90-1667-0.15%
2024/03/19187.1000.0086.9016560.15%
2024/03/15288.8000.0088.4026500.31%
2024/03/0600.00292.4091.50-2639-0.31%
2024/03/05392.530.192.8092.102.96390.45%
2024/02/2200.001.394.3294.00-1.3727-0.18%
2024/02/2000.00494.9395.00-4879-0.46%
2024/02/15191.9000.0092.0018770.11%
2024/01/291990.64996.1395.50109011.11%
2024/01/17195.8000.0095.6011,0540.09%
2024/01/1500.00198.2098.00-11,132-0.09%
2024/01/030.1102.0000.00101.000.11,1420.01%
2024/01/021101.0000.00102.5011,1430.09%
〈熱門股〉台康生技美國FDA藥證申請未過 周跌逾2成Anue鉅亨-12天前
台康抗癌生物相似性藥獲歐盟 CHMP 推薦 有望第4季上市UDN聯合新聞網-2023/09/18
台康生技 相關文章
台康生技 相關影音